Phase 1 trial of CD19/CD20 bispecific chimeric antigen receptor-engineered naive/memory T cells for relapsed or refractory non-Hodgkin lymphoma
Benjamin R. Puliafito,Christopher Walthers,Brenda Ji,Sanaz N. Ghafouri,Jacob Naparstek,Jacqueline Trent, Jia M. Chen,Mobina Roshandell,Caitlin Harris,Mobina Khericha,Thomas Schweppe,Beata Berent-Maoz, Stanley B. Gosliner, Amr Almaktari, Melanie Ayala Ceja,Martin S. Allen-Auerbach,Jonathan Said,Karla Nawaly,Monica Mead,Sven de Vos,Patricia A. Young,Caspian Oliai,Gary J. Schiller,John M. Timmerman,Antoni Ribas,Yvonne Y. Chen,Sarah M. Larson CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例